DANDIKER; Yogesh
Patent Applications and Registrations
Patent applications and USPTO patent grants for DANDIKER; Yogesh.The latest application filed is for "atomoxetine hydrochloride extended release compositions and methods of use".
- DANDIKER; Yogesh - Edina MN
- Dandiker; Yogesh - Toronto N/A CA
| Patent | Date |
|---|---|
| Atomoxetine Hydrochloride Extended Release Compositions And Methods Of Use App 20220241222 - DANDIKER; Yogesh ; et al. | 2022-08-04 |
| Compositions Of Midodrine And Methods Of Using The Same App 20220175679 - DANDIKER; Yogesh ; et al. | 2022-06-09 |
| Compositions of midodrine and methods of using the same Grant 11,202,760 - Dandiker , et al. December 21, 2 | 2021-12-21 |
| Testosterone And Estradiol Transdermal Spray App 20210236514 - DANDIKER; Yogesh | 2021-08-05 |
| Oxycodone And Methylnaltrexone Multiparticulates And Suspensions Containing Them App 20210128549 - DANDIKER; Yogesh ; et al. | 2021-05-06 |
| Extended Release Midodrine Hydrochloride Compositions And Methods Of Use App 20200338025 - DANDIKER; Yogesh ; et al. | 2020-10-29 |
| Testosterone Transdermal Spray With Film App 20200330397 - DANDIKER; Yogesh ; et al. | 2020-10-22 |
| Application for topical composition Grant 10,555,592 - Dandiker , et al. Feb | 2020-02-11 |
| Compositions Of Midodrine And Methods Of Using The Same App 20200022919 - DANDIKER; Yogesh ; et al. | 2020-01-23 |
| Droxidopa Compositions And Methods App 20190321318 - DANDIKER; Yogesh ; et al. | 2019-10-24 |
| Application For Topical Composition App 20190059552 - Dandiker; Yogesh ; et al. | 2019-02-28 |
| Oral formulations of cladribine Grant 8,785,415 - Bodor , et al. July 22, 2 | 2014-07-22 |
| Oral Formulations Of Cladribine App 20110097306 - Bodor; Nicholas S. ; et al. | 2011-04-28 |
| Oral formulations of cladribine Grant 7,888,328 - Bodor , et al. February 15, 2 | 2011-02-15 |
| Oral formulations of cladribine App 20070197468 - Bodor; Nicholas S. ; et al. | 2007-08-23 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 